(2E)-(R)-5-(Diphenylamino)-5-oxopent-3-en-2-yl 3-(5-nitrocyclohex-1-en-1-yl)acrylate

(2E)-(R)-5-(Diphenylamino)-5-oxopent-3-en-2-yl 3-(5-nitrocyclohex-1-en-1-yl)acrylate

Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.

Specifications

Product Name:                  (2E)-(R)-5-(Diphenylamino)-5-oxopent-3-en-2-yl 3-(5-nitrocyclohex-1-en-1-yl)acrylate

Synonyms:                         N/A

CAS Number:                     900186-73-4

Molecular Weight:            446.5018

Molecular Formula:          C26H26N2O5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(O[C@@H](C=CC(N(C3=CC=CC=C3)C2=CC=CC=C2)=O)C)/C=C/C1=CCCC([N+]([O-])=O)C1

  • $1,500.00
  • Ex Tax: $1,500.00

Available Options